Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: Subdivision and comparison with ordinary hepatocellular carcinoma

American Journal of Surgical Pathology

Volumn 31, Issue 5, 2007, Pages 783-791

  Aishima, Shinichi ^a,b   Nishihara, Yunosuke ^b   Kuroda, Yousuke ^b   Taguchi, Kenichi ^c   Iguchi, Tomohiro ^b   Taketomi, Akinobu ^b   Maehara, Yoshihiko ^b   Tsuneyoshi, Masazumi ^b  

^a HAMANOMACHI HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Biliary differentiation; Hepatic progenitor cell; Hepatocellular carcinoma; Mucin production; Prognosis

Indexed keywords

CYTOKERATIN 19; MUCIN; NERVE CELL ADHESION MOLECULE; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; BILIARY DIFFERENTIATION; CANCER CELL; CANCER SURVIVAL; CELL INFILTRATION; CELL STRUCTURE; CONTROLLED STUDY; DIFFERENTIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PROTEIN EXPRESSION; STROMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HEPATECTOMY; HUMANS; KERATIN-19; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUCINS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34247642682     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213421.53750.0a     Document Type: Article

References (30)

1. Aishima S, Kuroda Y, Asayama Y, et al. Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. Hum Pathol. 2006;37:283-291.
2. Ding SJ, Li Y, Tan YX, et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics. 2004;3:73-81.
3. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985;55:124-135.
4. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004;40:298-304.
5. Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006;12:410-416.
6. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002;13:389-396.
7. Libbrecht L, Desmet V, Van Damme B, et al. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol. 2000;192:373-378.
8. Libbrecht L, Desmet V, Van Damme B, et al. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol. 2000;33:76-84.
9. Liu Z, Sakamoto T, Ezure T, et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology. 1998;28:1260-1268.
10. Maeda T, Adachi E, Kajiyama K, et al. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Human Pathol 1995;26:956-964.
11. Matsuura S, Aishima S, Taguchi K, et al. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology. 2005;47:382-390.
12. Nam SW, Park JY, Ramasamy A, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology. 2005;42:809-818.
13. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellularcholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol. 1998;13:34-40.
14. Nishikawa Y, Doi Y, Watanabe H, et al. Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. Am J Pathol. 2005;166:1077-1088.
15. Robrechts C, De Vos R, Van den Heuvel M, et al. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver. 1998;18:288-293.
16. Roskams T, van den Oord JJ, De Vos R, et al. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol. 1990;137:1019-1025.
17. Roskams T, Willems M, Campos RV, et al. Parathyroid hormonerelated peptide expression in primary and metastatic liver tumours. Histopathology. 1993;23:519-525.
18. Roskams TA, Theise ND, Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology. 2004;39:1739-1745.
19. Sasaki M, Tsuneyama K, Ishikawa A, et al. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocytemacrophage colony-stimulating factor. Hum Pathol. 2003;34:1337-1344.
20. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology. 2001;33:738-750.
21. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol. 1989;134:1347-1363.
22. Taguchi J, Nakashima O, Tanaka M, et al. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol. 1996;11:758-764.
23. Theise ND, Yao JL, Harada K, et al. Hepatic 'stem cell' malignancies in adults: four cases. Histopathology 2003;43:263-271.
24. Tickoo SK, Zee SY, Obiekwe S, et al. Combined hepatocellularcholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol. 2002;26:989-997.
25. Uenishi T, Kubo S, Yamamoto T, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003;94:851-857.
26. Van Eyken P, Sciot R, Paterson A, et al. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol. 1988;19:562-568.
27. Wittekind C, Fischer HP, Ponchon T. Combined hepatocellular and cholangiocarcinoma. In: World Health Organization Classification of tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:181.
28. Wu PC, Fang JW, Lau VK, et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol. 1996; 149:1167-1175.
29. Wu PC, Lai VC, Fang JW, et al. Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J Hepatol. 1999;31:965-966.
30. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003;33:283-287.